VistaGen Therapeutics Inc. (VTGN) Slipped -5.13% or -0.06 To Price $1.13 On Tuesday

VistaGen Therapeutics Inc. (VTGN) slipped -5.13% or -0.06 to $1.13. It is approximately 194231 shares traded, which is 36.92% compare to the average total volume 526093. The market cap of VTGN is $25.86 million. The year to date change is 2.59%. The 52 week price range is from $0.69 to $2.65. Price of VTGN have changed 16.67% during last week. It have changed -6.30% over last month, -4.80% over last 3 months, -8.46% over last 6 months and -41.09% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for VTGN is 1.17. It is 3.54% above current price. The 200-day Moving Averages for VTGN is 1.36. It is 20.35% above current price. The 52-week High is 2.65. It is 134.51% from the current price. The 52-week Low is 0.69. It is -38.94% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of VTGN is 2.59 on 2018-03-29. Short % to float is 7.62%. There are some statistics of VTGN. It is has market cap $25.86 million. The share outstanding is 22.90 million. The average volume is 526093. It has 16.42M cash and 353900 in debt. The percent of top 15 Institution holding is 32.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of VTGN is -218.33%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of VTGN is -139.37%.


Share this post